Citations

Clear

3942 citation(s) found for "To, Van".

Feasibility of Instituting a Clinical Otolaryngology Human Papillomavirus (HPV) Vaccination Program
Palacios, Victoria J. , Merlino, Dante J. , Anderson, Stephanie S., Yeakel, Sarah R., Wiedermann, Joshua P. , Moore, Eric J. , O’Byrne, Thomas J., Abel, Kathryn M. Van , Choby, Garret , Moore, Eric J , O'Byrne, Thomas J, Jacobson, Robert M. , Van Abel, Kathryn M , Yeakel, Sarah, Choby, Garret

Mayo Clinic

The Laryngoscope | April 2, 2022 | Volume: 133 | Issue: 1 | Pages: 116-123

10.1002/lary.30130 | PMID 35366006 Get It

ObjectivesTo measure baseline human papillomavirus (HPV) vaccination rates among tertiary and community‐based Otolaryngology – Head and Neck Surgery (Oto‐HNS) clinic patients and to determine risk factors for under‐vaccination.MethodsRetrospective chart review of patients aged 9 to 26 years presenting to an Oto‐HNS clinic from 2017 to 2019. Patients were considered complete for HPV vaccination if they received two doses of HPV vaccine with the first dose received before age 15 years or three doses of HPV vaccine otherwise.Results8,532 unique patients met the criteria. At the index visit, 3,110 (36.5%) had completed the HPV series, 5,422 (63.5%) were due for one or more doses, with 4,981 (58.4%) eligible for vaccination at the time of their appointment. Of those dues, most (3,148/5,422 or 58%) were past due by age (≥13 years old). Of the 3,148 patients past due, 745 (23.7%) were partially vaccinated and 2,403 (76.3%) were vaccine naïve. Male sex and younger age were both independently associated with incomplete vaccination (p < 0.0001).ConclusionThis study demonstrates that the implementation of on‐site HPV vaccination has the potential to increase the opportunities for vaccination among vaccine‐eligible patients, especially among young males. Otolaryngologists have the potential to provide meaningful preventive services in the fight against HPV‐mediated disease.Level of Evidence3 Laryngoscope, 133:116–123, 2023
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics
König, Frederik , Grossmann, Nico C. , D’Andrea, David , Juvet, Tristan , Potretzke, Aaron M. , Djaladat, Hooman , Ghoreifi, Alireza , Kikuchi, Eiji , Hayakawa, Nozomi , Mari, Andrea , Khene, Z. , Fujita, Kazutoshi , Fontana, Matteo , Sfakianos, John P. , Pfail, John , Laukhtina, Ekaterina , Rajwa, Paweł , Pallauf, Maximilian , Cacciamani, Giovanni , Doeveren, Thomas van , Boormans, Joost L., Antonelli, Alessandro , Jamil, Marcus , Budzyn, Jeffrey, Ploussard, Guillaume , Heidenreich, Axel , Daneshmand, Siamak , Boorjian, Stephen A. , Rink, Michael , Shariat, Shahrokh F. , Pradère, Benjamin , D'Andrea, David , Juvet, Tristan , Potretzke, Aaron, Ghoreifi, Alireza , Kikuchi, Eiji , Mari, Andrea , Khene, Zine-Eddine , Fujita, Kazutoshi , Fontana, Matteo , Laukhtina, Ekaterina , Pallauf, Maximilian , Cacciamani, Giovanni E , van Doeveren, Thomas , Boormans, Joost L , Antonelli, Alessandro , Ploussard, Guillaume , Daneshmand, Siamak , Shariat, Shahrokh F , Pradere, Benjamin , Grossman, Nico C , Rajwa, Pawel , Soria, Francesco , Raman, Jay D. , Breda, Alberto , Abdollah, Firas , Rouprêt, Morgan

Mayo Clinic

Cancers | March 31, 2022 | Volume: 14 | Issue: 7 | Pages: 1781

10.3390/cancers14071781 | PMID 35406553 Get It

Background: Measuring quality of care indicators is important for clinicians and decision making in health care to improve patient outcomes. Objective: The primary objective was to identify quality of care indicators for patients with upper tract urothelial carcinoma (UTUC) and to validate these in an international cohort treated with radical nephroureterectomy (RNU). The secondary objective was to assess the factors associated with failure to validate the pentafecta. Design: We performed a retrospective multicenter study of patients treated with RNU for EAU high-risk (HR) UTUC. Outcome measurements and statistical analysis: Five quality indicators were consensually approved, including a negative surgical margin, a complete bladder-cuff resection, the absence of hematological complications, the absence of major complications, and the absence of a 12-month postoperative recurrence. After multiple imputations and propensity-score matching, log-rank tests and a Cox regression were used to assess the survival outcomes. Logistic regression analyses assessed predictors for pentafecta failure. Results: Among the 1718 included patients, 844 (49%) achieved the pentafecta. The median follow-up was 31 months. Patients who achieved the pentafecta had superior 5-year overall- (OS) and cancer-specific survival (CSS) compared to those who did not (68.7 vs. 50.1% and 79.8 vs. 62.7%, respectively, all p < 0.001). On multivariable analyses, achieving the pentafecta was associated with improved recurrence-free survival (RFS), CSS, and OS. No preoperative clinical factors predicted a failure to validate the pentafecta. Conclusions: Establishing quality indicators for UTUC may help define prognosis and improve patient care. We propose a pentafecta quality criteria in RNU patients. Approximately half of the patients evaluated herein reached this endpoint, which in turn was independently associated with survival outcomes. Extended validation is needed.
Accessory Genomes Drive Independent Spread of Carbapenem-Resistant Klebsiella pneumoniae Clonal Groups 258 and 307 in Houston, TX
Shropshire, William C. , Dinh, An Q , Earley, Michelle, Komarow, Lauren , Panesso, Diana , Rydell, Kirsten, Gómez-Villegas, Sara I, Miao, Hongyu , Hill, Carol , Chen, Liang , Patel, Robin , Abbo, Lilian M. , Cober, Eric , Revolinski, Sara , Luterbach, Courtney , Chambers, Henry F. , Fowler, Vance G. , Shelburne, Samuel A. , Kreiswirth, Barry N. , Hanson, Blake , Arias, César A. , Revolinski, Sara , Bonomo, Robert A , Shelburne, Samuel A , Kreiswirth, Barry N , van Duin, David , Hanson, Blake M , Chen, Liang , Patel, Robin , Abbo, Lilian M , Fries, Bettina C. , Fowler, Vance G. , Bonomo, Robert A. , Arias, César A.

Mayo Clinic

mBio | March 31, 2022 | Volume: 13 | Issue: 2 | Pages: No page available

10.1128/mbio.00497-22 | PMID 35357213 Get It

The prevalence of carbapenem-resistant Klebsiella pneumoniae (CR Kp ) infections in nosocomial settings remains a public health challenge. High-risk clones such as clonal group 258 (CG258) are particularly concerning due to their association with bla KPC carriage, which can severely complicate antimicrobial treatments.
Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure
Borlaug, Barry A. , Blair, John, Bergmann, Martin W., Bugger, Heiko, Burkhoff, Daniel , Bruch, Leonhard , Celermajer, David S. , Claggett, Brian , Cleland, John G.F., Cutlip, Donald E. , Dauber, Ira, Eicher, Jean-Christophe , Gao, Qi, Gorter, Thomas M. , Gustafsson, Finn , Heyden, Jan van der, Hasenfuß, Gerd, Hummel, Scott L. , Komtebedde, Jan, Mazurek, Jeremy A., McKenzie, Scott , Mehta, Shamir R. , Petrie, Mark C. , Post, Marco C., Nair, Ajith, Rieth, Andreas , Silvestry, Frank E., Solomon, Scott D. , Trochu, Jean‐Noël , Veldhuisen, Dirk J. Van, Westenfeld, Ralf, Leon, Martin B., Investigators, on behalf of the REDUCE LAP-HF-II, Bugger, Heiko , Nair, Ajith , Burkhoff, Daniel , Hayward, Chris , Hummel, Scott L , Kaye, David M , Massaro, Joseph M. , McKenzie, Scott , Mehta, Shamir R , Petrie, Mark C , Rieth, Andreas , Solomon, Scott David , Trochu, Jean-Noël , Shah, Sanjiv J , Borlaug, Barry A , Nair, Ajith P , Celermajer, David , Gustafsson, Finn , Blair, John, Bergmann, Martin W., Bruch, Leonhard , Claggett, Brian L , Cleland, John G.F., Cutlip, Donald E. , Dauber, Ira, Eicher, Jean-Christophe , Gao, Qi, Gorter, Thomas M. , Heyden, Jan van der, Hasenfuß, Gerd, Komtebedde, Jan, Mazurek, Jeremy A., Post, Marco C., Nair, Ajith, Silvestry, Frank E., Veldhuisen, Dirk J. Van, Westenfeld, Ralf, Leon, Martin B., Investigators, on behalf of the REDUCE LAP-HF-II

Mayo Clinic

Circulation | March 31, 2022 | Volume: 145 | Issue: 21 | Pages: 1592-1604

10.1161/circulationaha.122.059486 | PMID 35354306 Get It

Background: In REDUCE LAP-HF II (A Study to Evaluate the Corvia Medical, Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure), implantation of an atrial shunt device did not provide overall clinical benefit for patients with heart failure with preserved or mildly reduced ejection fraction. However, prespecified analyses identified differences in response in subgroups defined by pulmonary artery systolic pressure during submaximal exercise, right atrial volume, and sex. Shunt implantation reduces left atrial pressures but increases pulmonary blood flow, which may be poorly tolerated in patients with pulmonary vascular disease (PVD). On the basis of these results, we hypothesized that patients with latent PVD, defined as elevated pulmonary vascular resistance during exercise, might be harmed by shunt implantation, and conversely that patients without PVD might benefit. Methods: REDUCE LAP-HF II enrolled 626 patients with heart failure, ejection fraction ≥40%, exercise pulmonary capillary wedge pressure ≥25 mm Hg, and resting pulmonary vascular resistance <3.5 Wood units who were randomized 1:1 to atrial shunt device or sham control. The primary outcome—a hierarchical composite of cardiovascular death, nonfatal ischemic stroke, recurrent HF events, and change in health status—was analyzed using the win ratio. Latent PVD was defined as pulmonary vascular resistance ≥1.74 Wood units (highest tertile) at peak exercise, measured before randomization. Results: Compared with patients without PVD (n=382), those with latent PVD (n=188) were older, had more atrial fibrillation and right heart dysfunction, and were more likely to have elevated left atrial pressure at rest. Shunt treatment was associated with worse outcomes in patients with PVD (win ratio, 0.60 [95% CI, 0.42, 0.86]; P =0.005) and signal of clinical benefit in patients without PVD (win ratio, 1.31 [95% CI, 1.02, 1.68]; P =0.038). Patients with larger right atrial volumes and men had worse outcomes with the device and both groups were more likely to have pacemakers, heart failure with mildly reduced ejection fraction, and increased left atrial volume. For patients without latent PVD or pacemaker (n=313; 50% of randomized patients), shunt treatment resulted in more robust signal of clinical benefit (win ratio, 1.51 [95% CI, 1.14, 2.00]; P =0.004). Conclusions: In patients with heart failure with preserved or mildly reduced ejection fraction, the presence of latent PVD uncovered by invasive hemodynamic exercise testing identifies patients who may worsen with atrial shunt therapy, whereas those without latent PVD may benefit.
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy
Miller, Devon , Livingston, J. Andrew , Park, Yeonhee , Posey, Kristi, Godbole, Sonia, Skubitz, Keith M. , Agulnik, Mark , Davis, Lara E. , Tine, Brian A. Van , Livingston, John A , Skubitz, Keith , Agulnik, Mark , Davis, Lara E , Van Tine, Brian A , Hirbe, Angela C , Parkes, Amanda , Robinson, Steven I. , Hirbe, Angela C.

Mayo Clinic

Cancer Medicine | March 28, 2022 | Volume: 11 | Issue: 18 | Pages: 3471-3478

10.1002/cam4.4707 | PMID 35343652 Get It

AbstractBackgroundSarcomas are rare diagnoses but are seen with relative frequency in adolescents and young adults and thus can present in pregnancy. We sought to study the administration of anthracyclines and/or ifosfamide in pregnancy‐associated sarcomas.Patients and MethodsWe conducted a multi‐institutional retrospective study, identifying sarcoma patients who received anthracyclines and/or ifosfamide during pregnancy. Chart review identified variables related to demographics, cancer diagnosis, therapies, and outcome of the patient and fetus. Wilcoxon rank‐sum test compared two independent samples.ResultsWe identified 13 patients at seven institutions with sarcoma who received anthracyclines and/or ifosfamide during pregnancy, including four bone sarcomas and nine soft tissue sarcomas diagnosed at a mean gestational age of 16.7 ± 5.9 weeks. Only nine patients had live births (9/13, 69.2%), with mean gestational age of 30.8 ± 3.8 weeks at delivery. The four patients with pregnancy loss all received both doxorubicin and ifosfamide, with chemotherapy initiated at 15.5 weeks as compared with 21.3 weeks for those patients with live births (p = 0.016).ConclusionIn this multi‐institutional study of sarcoma chemotherapy regimens administered during pregnancy, we found a high rate of fetal demise that was seen only in patients receiving both doxorubicin and ifosfamide and statistically more likely with chemotherapy initiation earlier in the second trimester. While limited by a small sample size, our study represents the largest study of sarcoma patients that received anthracyclines and/or ifosfamide in pregnancy thus far reported and supports development of an international registry to study concerns raised by our study.
A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration
Wu, Xinhui , Bos, I. Sophie T., Conlon, Thomas M. , Ansari, Meshal , Verschut, Vicky, Koog, Luke van der , Verkleij, Lars A., D’Ambrosi, Angela, Matveyenko, Aleksey V. , Schiller, Herbert B. , Königshoff, Mélanie , Schmidt, Martina , Kistemaker, Loes , van der Koog, Luke , Matveyenko, Aleksey V , Yildirim, Ali Önder , Gosens, Reinoud , Gosens, Reinoud

Mayo Clinic

Science Advances | March 23, 2022 | Volume: 8 | Issue: 12 | Pages: No page available

10.1126/sciadv.abj9949 | PMID 35319981 Get It

Currently, there is no pharmacological treatment targeting defective tissue repair in chronic disease. Here, we used a transcriptomics-guided drug target discovery strategy using gene signatures of smoking-associated chronic obstructive pulmonary disease (COPD) and from mice chronically exposed to cigarette smoke, identifying druggable targets expressed in alveolar epithelial progenitors, of which we screened the function in lung organoids. We found several drug targets with regenerative potential, of which EP and IP prostanoid receptor ligands had the most profound therapeutic potential in restoring cigarette smoke–induced defects in alveolar epithelial progenitors in vitro and in vivo. Mechanistically, we found, using single-cell RNA sequencing analysis, that circadian clock and cell cycle/apoptosis signaling pathways were differentially expressed in alveolar epithelial progenitor cells in patients with COPD and in a relevant model of COPD, which was prevented by prostaglandin E2 or prostacyclin mimetics. We conclude that specific targeting of EP and IP receptors offers therapeutic potential for injury to repair in COPD.
Social Media and Professional Development for Oncology Professionals
Chidharla, Anusha , Attai, Deanna J. , Drake, Emily K. , Londen, G. J. van , Subbiah, Ishwaria M. , Henry, Elizabeth , Murphy, Martina, Barry, Maura , Manochakian, Rami , Leyfman, Yan , Utengen, Audun , Attai, Deanna J , Drake, Emily K , van Londen, G J , Subbiah, Ishwaria M , Henry, Elizabeth , Barry, Maura M , Manochakian, Rami , Moerdler, Scott , Loeb, Stacy , Graff, Stephanie L , Leyfman, Yan , Thompson, Michael A , Markham, Merry J , Utengen, Audun , Loeb, Stacy , Graff, Stephanie L. , Thompson, Michael A, Markham, Merry Jennifer

Mayo Clinic

JCO Oncology Practice | March 21, 2022 | Volume: 18 | Issue: 8 | Pages: 566-571

10.1200/op.21.00761 | PMID 35312343 Get It

The use of social media continues to increase in health care and academia. Health care practice, particularly the oncologic field, is constantly changing because of new knowledge, evidence-based research, clinical trials, and government policies. Therefore, oncology trainees and professionals continue to strive to stay up-to-date with practice guidelines, research, and skills. Although social media as an educational and professional development tool is no longer completely new to medicine and has been embraced, it is still under-researched in terms of various outcomes. Social media plays several key roles in professional development and academic advancement. We reviewed the literature to evaluate how social media can be used for professional development and academic promotion of oncology professionals.
Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
Iovleva, Alina , Mustapha, Mustapha M. , Griffith, M. Patrick , Komarow, Lauren , Luterbach, Courtney , Evans, Daniel R. , Cober, Eric , Richter, Sandra S. , Rydell, Kirsten, Arias, César A. , Jacob, Jesse T. , Salata, Robert A. , Satlin, Michael J. , Wong, Darren , Tyne, Daria Van , Doi, Yohei , Bonomo, Robert A , van Duin, David , Cooper, Vaughn S , Van Tyne, Daria , Doi, Yohei , Jacob, Jesse T , Griffith, Marissa P., Arias, César A. , Bonomo, Robert A.

Mayo Clinic

mBio | March 21, 2022 | Volume: 13 | Issue: 2 | Pages: No page available

10.1128/mbio.02759-21 | PMID 35311529 Get It

Carbapenem-resistant Acinetobacter baumannii (CR Ab ) constitutes a major threat to public health. To elucidate the molecular and clinical epidemiology of CR Ab in the United States, clinical CR Ab isolates were collected along with data on patient characteristics and outcomes, and bacterial isolates underwent whole-genome sequencing and antibiotic susceptibility phenotyping.
The Value of Passive Leg Raise During Right Heart Catheterization in Diagnosing Heart Failure With Preserved Ejection Fraction
Bovenkamp, Arno A. van de , Wijkstra, Niels, Oosterveer, Frank, Noordegraaf, Anton Vonk , Bogaard, Harm Jan , Rossum, Albert C. van , Man, Frances S. de , Borlaug, Barry A. , Handoko, M. Louis , van de Bovenkamp, Arno A , Vonk Noordegraaf, Anton , van Rossum, Albert C , de Man, Frances S , Borlaug, Barry A

Mayo Clinic

Circulation: Heart Failure | March 21, 2022 | Volume: 15 | Issue: 4 | Pages: No page available

10.1161/circheartfailure.121.008935 | PMID 35311526 Get It

Background: Because of limited accuracy of noninvasive tests, diastolic stress testing plays an important role in the diagnostic work-up of patients with heart failure with preserved ejection fraction (HFpEF). Exercise right heart catheterization is considered the gold standard and indicated when HFpEF is suspected but left ventricular filling pressures at rest are normal. However, performing exercise during right heart catheterization is not universally available. Here, we examined whether pulmonary capillary wedge pressure (PCWP) during a passive leg raise (PLR) could be used as simple and accurate method to diagnose or rule out occult-HFpEF. Methods: In our tertiary center for pulmonary hypertension and HFpEF, all patients who received a diagnostic right heart catheterization with PCWP-measurements at rest, PLR, and exercise were evaluated (2014–2020). The diagnostic value of PCWP PLR was compared with the gold standard (PCWP EXERCISE ). Cut-offs derived from our cohort were subsequently validated in an external cohort (N=74). Results: Thirty-nine non-HFpEF, 33 occult-HFpEF, and 37 manifest-HFpEF patients were included (N=109). In patients with normal PCWP REST (<15 mmHg), PCWP PLR significantly improved diagnostic accuracy compared with PCWP REST (AUC=0.82 versus 0.69, P =0.03). PCWP PLR ≥19 mmHg (24% of cases) had a specificity of 100% for diagnosing occult-HFpEF, irrespective of diuretic use. PCWP PLR ≥11 mmHg had a 100% sensitivity and negative predictive value for diagnosing occult-HFpEF. Both cut-offs retained a 100% specificity and 100% sensitivity in the external cohort. Absolute change in PCWP PLR or V-wave derived parameters had no incremental value in diagnosing occult-HFpEF. Conclusions: PCWP PLR is a simple and powerful tool that can help to diagnose or rule out occult-HFpEF.
Abstract 10332: Biventricular Function and Shock Severity Predicts Mortality in Cardiac Intensive Care Unit Patients
Burstein, Barry , Anavekar, Nandan S., Diepen, Sean van , Wiley, Brandon M. , Jentzer, Jacob C.

Mayo Clinic

Circulation | March 19, 2022 | Volume: 144 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.144.suppl_1.10332 Get It

Introduction: Ventricular dysfunction contributes to shock in cardiac intensive care unit (CICU) patients. We aimed to describe the associations between ventricular dysfunction with in-hospital mortality across the spectrum of shock severity. Hypothesis: Patients with biventricular dysfunction (BVD) have higher mortality at each Society for Cardiovascular Angiography and Intervention (SCAI) shock stage. Methods: We identified CICU patients from 2007 to 2015 with available echocardiography data within 1 day of admission. Left ventricular systolic dysfunction (LVSD) was defined as left ventricular ejection fraction <40% and right ventricular systolic dysfunction (RVSD) as moderate or greater systolic dysfunction by semi-quantitative assessment; BVD included the presence of both LVSD and RVSD. Predictors of in-hospital mortality were determined after adjustment using multivariable logistic regression. Results: We included 3,158 patients with a mean age of 68.2±14.6 years; 51.8% had acute coronary syndromes. LVSD was present in 22.3%, RVSD in 11.8%, and 16.4% had BVD. Hospital mortality increased with SCAI shock stage and was incrementally higher in patients with LVSD, RVSD and BVD across SCAI shock stages (Figure); patients with BVD had higher mortality in each SCAI shock stage. After adjustment, there was no difference in in-hospital mortality for patients with LVSD or RVSD versus those without ventricular dysfunction (p >0.05), but BVD was independently associated with higher in-hospital mortality (adjusted HR 1.815, 95% CI 1.237-2.663, p = 0.0023). Adding ventricular dysfunction to SCAI shock stage increased discrimination for hospital mortality (AUC 0.784 vs. 0.766, p <0.001). Conclusions: Among patients admitted to the CICU, BVD was independently associated with higher hospital mortality after adjustment for shock severity. Echocardiographic assessment may augment clinical risk stratification using the SCAI shock classification.